Literature DB >> 31299656

Infuse-as-you-go convective delivery to enhance coverage of elongated brain targets: technical note.

Vivek Sudhakar1, Jerusha Naidoo1, Lluis Samaranch1, John R Bringas1, Russell R Lonser2, Massimo S Fiandaca1, Krystof S Bankiewicz1,2.   

Abstract

OBJECTIVE: To develop and assess a convective delivery technique that enhances the effectiveness of drug delivery to nonspherical brain nuclei, the authors developed an occipital "infuse-as-you-go" approach to the putamen and compared it to the currently used transfrontal approach.
METHODS: Eleven nonhuman primates received a bilateral putamen injection of adeno-associated virus with 2 mM gadolinium-DTPA by real-time MR-guided convective perfusion via either a transfrontal (n = 5) or occipital infuse-as-you-go (n = 6) approach.
RESULTS: MRI provided contemporaneous assessment and monitoring of putaminal infusions for transfrontal (2 to 3 infusion deposits) and occipital infuse-as-you-go (stepwise infusions) putaminal approaches. The infuse-as-you-go technique was more efficient than the transfrontal approach (mean 35 ± 1.1 vs 88 ± 8.3 minutes [SEM; p < 0.001]). More effective perfusion of the postcommissural and total putamen was achieved with the infuse-as-you-go versus transfronatal approaches (100-µl infusion volumes; mean posterior commissural coverage 76.2% ± 5.0% vs 32.8% ± 2.9% [p < 0.001]; and mean total coverage 53.5% ± 3.0% vs 38.9% ± 2.3% [p < 0.01]).
CONCLUSIONS: The infuse-as-you-go approach, paralleling the longitudinal axis of the target structure, provides a more effective and efficient method for convective infusate coverage of elongated, irregularly shaped subcortical brain nuclei.

Entities:  

Keywords:  AC-PC = anterior commissure–posterior commissure; CED = convection-enhanced delivery; MCP = midcommissural point; NHP = nonhuman primate; PD = Parkinson’s disease; Parkinson’s disease; convection-enhanced delivery; gene therapy; infusion; putamen; surgical technique

Year:  2019        PMID: 31299656     DOI: 10.3171/2019.4.JNS19826

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  5 in total

1.  Convection-enhanced delivery with controlled catheter movement: A parametric finite element analysis.

Authors:  Jason N Mehta; Manuel K Rausch; Christopher G Rylander
Journal:  Int J Numer Method Biomed Eng       Date:  2022-07-15       Impact factor: 2.648

2.  Constant Pressure Convection-Enhanced Delivery Increases Volume Dispersed With Catheter Movement in Agarose.

Authors:  Jason N Mehta; Brianna E Morales; Fang-Chi Hsu; John H Rossmeisl; Christopher G Rylander
Journal:  J Biomech Eng       Date:  2022-11-01       Impact factor: 1.899

Review 3.  Data-driven evolution of neurosurgical gene therapy delivery in Parkinson's disease.

Authors:  R Mark Richardson; Krystof S Bankiewicz; Chadwick W Christine; Amber D Van Laar; Robert E Gross; Russell Lonser; Stewart A Factor; Sandra K Kostyk; Adrian P Kells; Bernard Ravina; Paul S Larson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-07-30       Impact factor: 10.154

4.  PET, image-guided HDAC inhibition of pediatric diffuse midline glioma improves survival in murine models.

Authors:  Umberto Tosi; Harikrishna Kommidi; Oluwaseyi Adeuyan; Hua Guo; Uday Bhanu Maachani; Nandi Chen; Taojunfeng Su; Guoan Zhang; David J Pisapia; Nadia Dahmane; Richard Ting; Mark M Souweidane
Journal:  Sci Adv       Date:  2020-07-24       Impact factor: 14.136

Review 5.  An Update on Gene Therapy Approaches for Parkinson's Disease: Restoration of Dopaminergic Function.

Authors:  Amber D Van Laar; Victor S Van Laar; Waldy San Sebastian; Aristide Merola; J Bradley Elder; Russell R Lonser; Krystof S Bankiewicz
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.